AIP
IOVA icon

Ameritas Investment Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Ameritas Investment Partners’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Buy
36,118
+8,511
+31% +$32.3K ﹤0.01% 1580
2026
Q1 		$96.9K Buy
27,607
+2,193
+9% +$7.01K ﹤0.01% 1710
2025
Q4 		$69.4K Buy
25,414
+3,600
+17% +$8.33K ﹤0.01% 1914
2025
Q3 		$47.3K Sell
21,814
-6,915
-24% -$16.3K ﹤0.01% 2168
2025
Q2 		$49.4K Hold
28,729
– – ﹤0.01% 2193
2025
Q1 		$95.7K Hold
28,729
– – ﹤0.01% 1741
2024
Q4 		$213K Buy
28,729
+3,924
+16% +$36.4K 0.01% 1286
2024
Q3 		$233K Hold
24,805
– – 0.01% 1213
2024
Q2 		$199K Buy
24,805
+1,816
+8% +$19.5K 0.01% 1269
2024
Q1 		$341K Hold
22,989
– – 0.01% 975
2023
Q4 		$187K Hold
22,989
– – 0.01% 1304
2023
Q3 		$105K Buy
22,989
+5,809
+34% +$37.9K ﹤0.01% 1627
2023
Q2 		$121K Buy
17,180
+5,872
+52% +$42K ﹤0.01% 1471
2023
Q1 		$69.1K Hold
11,308
– – ﹤0.01% 1773
2022
Q4 		$79.2K Hold
11,308
– – ﹤0.01% 1753
2022
Q3 		$108K Hold
11,308
– – ﹤0.01% 1431
2022
Q2 		$124K Buy
+11,308
New +$148K 0.01% 1361
2020
Q2 		– Sell
-10,222
Closed -$306K – 3096
2020
Q1 		$306K Buy
10,222
+147
+1% +$3.9K 0.02% 773
2019
Q4 		$279K Buy
10,075
+308
+3% +$7.01K 0.01% 920
2019
Q3 		$178K Hold
9,767
– – 0.01% 1115
2019
Q2 		$239K Buy
9,767
+1,009
+12% +$15.2K 0.01% 976
2019
Q1 		$83K Hold
8,758
– – ﹤0.01% 1587
2018
Q4 		$78K Buy
8,758
+1,750
+25% +$16.9K ﹤0.01% 1551
2018
Q3 		$79K Hold
7,008
– – ﹤0.01% 1706
2018
Q2 		$90K Buy
7,008
+785
+13% +$11.5K ﹤0.01% 1609
2018
Q1 		$105K Buy
6,223
+1,632
+36% +$24.7K 0.01% 1457
2017
Q4 		$37K Hold
4,591
– – ﹤0.01% 2091
2017
Q3 		$26K Hold
4,591
– – ﹤0.01% 2279
2017
Q2 		$34K Hold
4,591
– – ﹤0.01% 2148
2017
Q1 		$34K Buy
+4,591
New +$33.6K ﹤0.01% 2090

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Ameritas Investment Partners's IOVA Position: Q2 2026 in Review

Ameritas Investment Partners increased its Iovance Biotherapeutics (IOVA) stake by 31% in Q2 2026, buying an estimated $32.3K and bringing the position to 36,118 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Ameritas Investment Partners first reported a position in IOVA in Q1 2017 and has held it in 30 quarters since. The position peaked at $341K in Q1 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Ameritas Investment Partners held 36,118 shares of Iovance Biotherapeutics worth $150K as of Q2 2026.
  • Ameritas Investment Partners bought 8,511 Iovance Biotherapeutics shares in Q2 2026, an estimated $32.3K.
  • Iovance Biotherapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1580 holding.
  • Ameritas Investment Partners first reported a position in Iovance Biotherapeutics in Q1 2017 and has held it in 30 quarters since.
  • Ameritas Investment Partners's Iovance Biotherapeutics position peaked at $341K in Q1 2024.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.